Claire Drysdale
Biochemistry, Genetics and Molecular Biology · University of Michigan
Publications
35
Citations
450
Est. group size
~16
Recurring co-author estimate
Active years
9
Publishing since 2018
Typically publishes in teams of ~12 · 14% small-team papers (≤3 authors) · across 12 venues
- The Saga Complex Member TADA2B Is a Novel Regulator of γ-Globin Production
Blood · 2024
- Cas9 protein delivery non-integrating lentiviral vectors for gene correction in sickle cell disease
Molecular Therapy — Methods & Clinical Development · 2021
- Hematopoietic Stem Cell-Targeted Gene-Addition and Gene-Editing Strategies for β-hemoglobinopathies
Cell stem cell · 2021
- Preclinical evaluation for engraftment of CD34+ cells gene-edited at the sickle cell disease locus in xenograft mouse and non-human primate models
Cell Reports Medicine · 2021
- Sustained fetal hemoglobin induction in vivo is achieved by <i>BCL11A</i> interference and coexpressed truncated erythropoietin receptor
Science Translational Medicine · 2021
- BCL11A enhancer–edited hematopoietic stem cells persist in rhesus monkeys without toxicity
Journal of Clinical Investigation · 2020
- Definitive hematopoietic stem/progenitor cells from human embryonic stem cells through serum/feeder-free organoid-induced differentiation
Stem Cell Research & Therapy · 2020
- βT87Q-Globin Gene Therapy Reduces Sickle Hemoglobin Production, Allowing for Ex Vivo Anti-sickling Activity in Human Erythroid Cells
Molecular Therapy — Methods & Clinical Development · 2020
- Correction to: Definitive hematopoietic stem/progenitor cells from human embryonic stem cells through serum/feeder-free organoid-induced differentiation
Stem Cell Research & Therapy · 2020
- Additional file 13 of Definitive hematopoietic stem/progenitor cells from human embryonic stem cells through serum/feeder-free organoid-induced differentiation
Figshare · 2020
- High-Efficiency Lentiviral Transduction of Human CD34+ Cells in High-Density Culture with Poloxamer and Prostaglandin E2
Molecular Therapy — Methods & Clinical Development · 2019
- Busulfan Combined with Immunosuppression Allows Efficient Engraftment of Gene-Modified Cells in a Rhesus Macaque Model
Molecular Therapy · 2019
- Low-Dose Busulfan Reduces Human CD34+ Cell Doses Required for Engraftment in c-kit Mutant Immunodeficient Mice
Molecular Therapy — Methods & Clinical Development · 2019
- Immunoresponse to Gene-Modified Hematopoietic Stem Cells
Molecular Therapy — Methods & Clinical Development · 2019
- Ex vivo immunological evaluation of stable mixed chimeric patients after matched related donor allogeneic transplantation in sickle cell disease
Cytotherapy · 2019
- Blood×14
- Molecular Therapy — Methods & Clinical Development×5
- Stem Cell Research & Therapy×2
- Science Translational Medicine×2
- Journal of Clinical Investigation×1
- Zesen Lin
Biochemistry, Genetics and Molecular Biology · University of Michigan
- Ginette Balbin-Cuesta
Biochemistry, Genetics and Molecular Biology · University of Michigan
- Na Tang
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Gregory Nagy
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Kara M. Braunreiter
Biochemistry, Genetics and Molecular Biology · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile